TGFB1 and liver dysplastic nodule: However, the efficacy of anti-TGF-β antibody Fresolimumab (1D11), a monoclonal antibody that recognizes all three TGF-β isoforms, was significantly diminished in its renoprotection if initiated during the advanced stages of DN in streptozotocin-injected rats 146.